2018
DOI: 10.1007/s11010-018-3347-3
|View full text |Cite
|
Sign up to set email alerts
|

A novel, semi-synthetic diterpenoid 16(R and S)-phenylamino-cleroda-3,13(14), Z-dien-15,16 olide (PGEA-AN) inhibits the growth and cell survival of human neuroblastoma cell line SH-SY5Y by modulating P53 pathway

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
8
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(9 citation statements)
references
References 38 publications
1
8
0
Order By: Relevance
“…The same group showed that enteric-coated nanoparticles of CD with intraperitoneal injection displayed more potently effective dosage with 0.16 mg/kgw/daily for a 10-day treatment period [43]. Hussain et al (2018) evaluated a semi-synthetic diterpenoid, 16(R&S) phenylaminocleroda-3,13(14)Z-dien-15,16 olide (derived from 16-oxocleroda-3,13(14)E-dien-15-oic acid (41), which could inhibit neuroblastoma SH-5Y5 cell proliferation through modulating the p53 pathway and apoptosis [113]. The IC 50 of this semi-synthetic compound is 12.5 µM for 48 h of treatment in SH-5Y5 cells, which could be comparative with cisplatin administration [113].…”
Section: Anti-cancer Potential Of Polyalthia Genusmentioning
confidence: 99%
See 1 more Smart Citation
“…The same group showed that enteric-coated nanoparticles of CD with intraperitoneal injection displayed more potently effective dosage with 0.16 mg/kgw/daily for a 10-day treatment period [43]. Hussain et al (2018) evaluated a semi-synthetic diterpenoid, 16(R&S) phenylaminocleroda-3,13(14)Z-dien-15,16 olide (derived from 16-oxocleroda-3,13(14)E-dien-15-oic acid (41), which could inhibit neuroblastoma SH-5Y5 cell proliferation through modulating the p53 pathway and apoptosis [113]. The IC 50 of this semi-synthetic compound is 12.5 µM for 48 h of treatment in SH-5Y5 cells, which could be comparative with cisplatin administration [113].…”
Section: Anti-cancer Potential Of Polyalthia Genusmentioning
confidence: 99%
“…Hussain et al (2018) evaluated a semi-synthetic diterpenoid, 16(R&S) phenylaminocleroda-3,13(14)Z-dien-15,16 olide (derived from 16-oxocleroda-3,13(14)E-dien-15-oic acid (41), which could inhibit neuroblastoma SH-5Y5 cell proliferation through modulating the p53 pathway and apoptosis [113]. The IC 50 of this semi-synthetic compound is 12.5 µM for 48 h of treatment in SH-5Y5 cells, which could be comparative with cisplatin administration [113]. Additionally, authors suggested that this agent did not affect the renal system in vivo, which could be considered for further cancer treatment.…”
Section: Anti-cancer Potential Of Polyalthia Genusmentioning
confidence: 99%
“…Neuroblastoma (NB) is the most frequently diagnosed solid extracranial malignant tumor in the pediatric population and accounts for 15% of malignancy-related death in early childhood. , Treatment options remain limited for 60% of patients with high-risk NB . The failure to respond to chemotherapeutic regimens and distant organ dissemination is correlated with the presence of CSCs that are not effectively eliminated by conventional chemotherapies .…”
Section: Introductionmentioning
confidence: 99%
“…Terpenoids are the largest class of natural compounds and are known for their anticancer activity. ( Hussain et al, 2018 ), explored the anticancer effects of a novel semi-synthetic terpenoid, 16-oxo-cleroda-3,13 (14)E-diene-15-oic acid 1), derived from cleroda diterpene isolated from Polyalthia longifolia var. pendula against neuroblastoma ( Faizi et al, 2008 ).…”
Section: Semi-synthetic Studies For New Drugs Derived From Natural Co...mentioning
confidence: 99%